Men can easily manage weight loss, hair growth and sexual wellness with Hims
Men can easily manage weight loss, hair growth and sexual wellness with Hims Get 24/7 virtual access to a Hims doctor to discuss weight loss, hair growth, sexual wellness and more.
GLP-1 Injections for weight loss
GLP-1 medications are dominating the weight loss industry and access has never been easier with virtual consultations and prescriptions shipped directly to you with Hims.
Consult a doctor on Hims
From weight loss and hair thinning to mental health and stress, men's health is no longer a taboo subject. Not only is Hims helping to start the conversation, but the company is rewriting the narrative to help empower men to take care of themselves. Most guys don't want to deal with in-person appointments or awkward encounters at the doctor's office or pharmacy. With Hims, you can meet with your provider virtually (depending on your state) or message them 24/7 from the palm of your hand.
Whether you're looking for a personalized weight loss plan with prescription medications, GLP-1 injections and even meal replacement protein products, or you're looking for a prescription-strength skincare routine that's tailored to your needs, Hims can help you.
Here's what you need to know about Hims and what the platform offers:
What is Hims?
Hims is a virtual care provider focused on men's healthcare. Through the program, you are matched with a licensed medical provider (depending on your state they may be able to provide online consultations) who can provide, if necessary, prescription medications for several health conditions, including: sexual performance, hair regrowth, skin care, weight loss and mental health.
Start Your Journey at Hims
What does Hims offer?
Weight loss injections aren't the only type of weight management support provided by Hims. Here's a look at a few of the other weight management tools offered:
Meal replacements for weight loss : Hims offers custom programs including protein shakes and protein bars
: Hims offers custom programs including protein shakes and protein bars Oral medication for weight loss: Hims doctors might also suggest a combination of oral medications, including B12, metformin and topiramate.
Viagra and Cialis for Sexual Wellness
No more suffering in silence, no more awkward encounters at the pharmacy. Hims gives you access to the sexual wellness medications you need without the embarrassment.
Consult a doctor on Hims
Minoxidil for Hair Loss and Thinning
To combat hair loss, Hims offers a variety of products including the prescription Minoxidil in multiple forms, including pills, shampoos and foams.
Consult a doctor on Hims
More: Struggling with hair thinning? This Nutrafol hair growth supplement is 25% off right now
Personalized, prescription-strength skincare
Skip the generic skincare routine and get prescription-strength skincare that's tailored to your needs, like acne or anti-aging.
Consult a doctor on Hims
Zoloft for Mental Health
Getting access to psychiatric care for anxiety and depression has never been easier, a medical professional at Hims can help determine if medication is right for you.
Consult with a doctor on Hims
How much does Hims cost?
Hims aims to provide accessible health care, without insurance, for an affordable price. There is no membership fee for Hims, you're only paying for your care, which can start as low as $1 per day. You also get the added benefit of free shipping on any prescriptions provided by your doctor.
What does a Hims subscription include?
With over one million subscribers, Hims is overhauling the medical industry. A subscription includes virtual consultations with your healthcare provider (if they're available in your state) without ever requiring insurance. Your medical provider can provide personalized treatment plans based on your needs and goals, with access like never before. You can message your medical support team 24/7 and ask questions or address concerns. If you need a prescription, they are discreetly delivered to your door, typically with free delivery (no more awkward pharmacy encounters). Plus, any follow-up calls are also virtual and free as part of your subscription.
Learn more about Hims
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
QPS Celebrates 30th Anniversary
NEWARK, Del., June 04, 2025--(BUSINESS WIRE)--QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in 2025. Founded by Dr. Benjamin Chien in 1995 to provide high-quality bioanalytical liquid chromatography with tandem mass spectrometry (LC-MS/MS) contract services, QPS is now recognized as a global leader in contract research. Over the past 30 years, the company has grown from a single office in Delaware, USA to a widely respected, global, full-service CRO with 8 locations spread across the US, EU, Asia, India and Australia, a clinical trial network of over 700 sites and an increased focus on leveraging the power of AI to accelerate clinical trials. Over the years, QPS has grown from a small molecule bioanalysis shop of three people to a global CRO with more than 1,200 employees. "30 years is a major milestone for QPS and I couldn't be more proud of the hard-working and innovative people who choose to work at QPS. They are the backbone of the company, and I am very grateful for their valuable contributions," said founder and CEO of QPS, Dr. Benjamin Chien. "Through QPS, the pharmaceutical and biotechnology industries have access to dedicated, focused scientific expertise across the drug development spectrum. In facilities around the world, QPS has assembled best-in-class instruments, platforms, people and processes required to conduct the studies necessary to support client drug discovery and development programs focused on obesity, type 2 diabetes, oncology, CNS diseases, cell and gene therapy, and more," said Dr. Chien. Since its humble beginnings, QPS has expanded its service options, to include pharmacology, DMPK, toxicology, bioanalysis, translational medicine, leukopaks, PBMCs, cell therapy products, clinical trials, central lab services, and a full range of clinical research services. QPS is known for high-quality data, technical expertise, delivery of promised study timelines, collaborative solutions, and customer-focused strategies. Going forward, QPS plans to continue delivering custom-built research services that accelerate pharmaceutical breakthroughs across the globe. ABOUT QPS HOLDINGS, LLC QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,200+ employees in the US, Europe, Asia and Australia. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, leukopaks, PBMCs and cell therapy products, clinical trials, and clinical research services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, and turnkey laboratories and facilities. Through continual enhancements in capacities and resources, QPS stands tall in its commitment to delivering superior quality, skilled performance and trusted service to its valued customers. For more information, visit or email info@ View source version on Contacts QPS CONTACT: Name: Gabrielle PastorePhone: 1-302-635-4290Email: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
3 hours ago
- Business Wire
IFF Unveils Game-Changing Outlook on GLP-1 Consumers
NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF), a global leader in food, beverage, and health and wellness, has released a new report highlighting how the rapidly growing GLP-1 consumer market is reshaping the sensory experience and nutritional needs associated with eating and drinking. The report outlines how food and beverage manufacturers can better support this emerging consumer segment with products that align with their evolving preferences. 'IFF is empowering our customers to lead the next wave of food and beverage innovations beyond traditional formulations, including helping GLP-1 consumers have choices they desire,' said Erik Fyrwald, IFF CEO. 'We aim to bring back the joy of eating and drinking by offering more healthy, great-tasting nutrition choices for all consumer segments, including GLP-1 users.' Disconnect on three levels Despite the rapid rise in GLP-1 medication use, most food and beverage products fall short of meeting the needs of these consumers—or aligning with how they now experience food. IFF has identified a disconnect on three key levels: Nutritional: GLP-1 users are eating less but require more from every bite and sip. They need nutrient-dense, smaller portions that efficiently deliver protein, fiber and hydration—without overwhelming flavors. Sensory: Eighty-five percent of GLP-1 consumers report significant changes in their food and beverage preferences. Common aversions include fatty foods, sweets, deli meats, coffee and alcohol. Dry, sticky or dense textures are also frequently rejected. Emotional: Many consumers are navigating a changed relationship with food—one that may involve a sense of loss, social disruption and a search for new meaning in nourishment. Understanding the GLP-1 Consumer Personas IFF is in the early stages of exploring GLP-1 consumer segmentation to help brands move beyond a one-size-fits-all approach toward one grounded in empathy, specificity and long-term relevance. The company's latest outlook introduces key consumer personas, which are expected to evolve over time: Health Hacker Holly: Proactive, data-driven and focused on long-term wellness, she views GLP-1 as part of a broader bio-optimization journey. She seeks functional benefits in formats such as protein bars, smoothies and enriched hydration blends, prioritizing high-quality protein, added fiber and digestive support. Remedy Reacher Ron: Often managing chronic conditions such as diabetes, he uses GLP-1 to reclaim his health and sees food as both medicine and maintenance. He looks for fortified snacks and gut-friendly options aligned with medical guidance, favoring meal kits and low-glycemic shakes. Glow Getter Gail: Transformation-minded and focused on lifestyle and self-image, she wants food that aligns with her goals and identity—aspirational yet approachable, with 'glow-up' appeal. She seeks portion-conscious indulgences, beauty-boosting nutrition and enjoyable flavors in formats such as smoothies, functional waters and shareable treats. The outlook also outlines how the food and beverage needs of each GLP-1 persona evolve over time. In the initial treatment phase, consumers need support managing smaller portion sizes and medication side effects. The transitional phase focuses on preventing regression, requiring flexible serving sizes and flavor intensity options that adapt to changing cravings. In the 'forever' phase, consumers seek to sustain their new routines with habit-forming formats for daily use, nutritional fortification and pre-portioned, high-satiety foods. Driving Empathy-Powered Innovation IFF has introduced a comprehensive framework to support food and beverage manufacturers in addressing the complex sensory and nutritional needs of GLP-1 consumers. The framework is designed to guide both the reformulation of existing products and the development of new offerings, tackling challenges such as muscle mass maintenance, satiety, digestive support and sensory preferences. To demonstrate practical applications, IFF has developed a suite of AI-refined, consumer-tested product concepts that show how manufacturers can optimize their portfolios for this rapidly expanding market. For more information, download the 2025 GLP-1 Consumer Opportunity Outlook here to uncover more insights and consumer-tested concepts. Welcome to IFF At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at X (Twitter), Facebook, Instagram, and LinkedIn. ©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.
Yahoo
3 hours ago
- Yahoo
Senate Agriculture committee considers Wilson for DEQ secretary
North Carolina Legislative Building (Photo: Galen Bacharier/NC Newsline) The North Carolina Senate Agriculture, Energy, and Environment Committee reviewed Reid Wilson's appointment as secretary of the Department of Environmental Quality during its hearing on Wednesday. The hearing was billed as 'discussion only.' Lawmakers will take a vote at their next meeting. Wilson formerly served as secretary for the Department of Natural and Cultural Resources from 2021 to 2024. Before that, he was DNCR's chief deputy secretary from 2017 to 2020. Following his appointment earlier this year by Gov. Josh Stein, he's been serving as DEQ secretary on an interim basis while awaiting confirmation. At the national level, Congress has been working on a federal budget that would include cuts to some of the areas under DEQ's purview. Sen. Jay Chaudhuri (D-Wake) asked what the cuts would mean to DEQ and how Wilson would respond. About half of DEQ's budget comes from federal sources, Wilson said. In particular, the proposed budget would remove $31.5 million from operating grants. 'We would have to let a whole lot of people go, and the consequences of that are that our permitting processes would take longer, our responses to spills and other problems would take longer, our responsiveness and assistance to businesses would not be as strong,' Wilson said. 'Everything we do, we would do less well.' Chaudhuri jokingly followed up with, 'Do you still want this job?' Wilson answered in the affirmative. Sen. Jim Burgin (R-Harnett, Lee, Sampson) asked about water quality, specifically microplastics. Wilson said DEQ staff are looking into the issue, and the department also collaborates with others like university researchers to learn more. 'Water quality is a huge priority,' he said. 'It is a significant health concern, so we're gonna' be involved with that.' After Hurricane Helene swept through the western portion of the state, DEQ worked closely with the U.S. Environmental Protection Agency to provide mobile programs testing the quality of drinking wells. Wilson said the agencies found out how polluted the drinking water was, how to get it cleaned, and tested it to make sure it was healthy before people drank it again. 'For folks with a well in the yard or on their property, they're more vulnerable, so we want to make sure we are doing as much testing,' Wilson said. 'We have a [fund] which helps pay for additional private well tests around the state when we determine that that is needed.' Lawmakers also voted to approve two pieces of legislation at Tuesday's meeting, which they discussed yesterday: House Bill 247 ('8-1-1 Amendments') and House Bill 694 ('Study Water/Wastewater Regionalization'). The former heads to the Senate Judiciary Committee and the latter proceeds to the Senate Rules Committee.
